Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and Gαi activation

被引:37
作者
Berchiche, Yamina A.
Chow, Ken Y.
Lagane, Bernard
Leduc, Martin
Percherancier, Yann
Fujii, Nobutaka
Tamamura, Hirokazu
Bachelerie, Francoise
Heveker, Nikolaus
机构
[1] Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada
[2] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada
[3] Inst Pasteur, Unite Pathogenie Virale Mol, F-75015 Paris, France
[4] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan
[5] Tokyo Med & Dent Univ, Dept Mol Recognit, Inst Biomat & Bioengn, Tokyo 1010062, Japan
关键词
D O I
10.1074/jbc.C600270200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ligand binding to G protein-coupled receptors (GPCRs) is thought to induce changes in receptor conformation that translate into activation of downstream effectors. The link between receptor conformation and activity is still insufficiently understood, as current models of GPCR activation fail to take an increasing amount of experimental data into account. To elucidate structure-function relationships in GPCR activation, we used bioluminescence resonance energy transfer to directly assess the conformation of mutants of the chemokine receptor CXCR4. We analyzed substitutions in the arginine cage DRY motif and in the conserved asparagine N(3.35)119, which are pivotal molecular switches for receptor conformation and activation. G alpha(i) activation of the mutants was either similar to wildtype CXCR4 (D133N, Y135A, and N119D) or resulted in loss of activity (R134A and N119K). Mutant N119S was constitutively active but further activated by agonist. Bioluminescence resonance energy transfer analysis suggested no simple correlation between conformational changes in response to ligand binding and activation of Gat by the mutants. Different conformations of active receptors were detected (for wild-type CXCR4, D133N, and N119S), suggesting that different receptor conformations are able to trigger Gai activity. Several conformations were also found for inactive mutants. These data provide biophysical evidence for different receptor conformations being active with respect to a single readout. They support models of GPCR structure-activity relationships that take this conformational flexibility of active receptors into account.
引用
收藏
页码:5111 / 5115
页数:5
相关论文
共 23 条
[1]   Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer [J].
Ayoub, MA ;
Couturier, C ;
Lucas-Meunier, E ;
Angers, S ;
Fossier, P ;
Bouvier, M ;
Jockers, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21522-21528
[2]  
Ballasteros J. A., 1995, Methods in neurosciences, V25, P366
[3]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[4]   Constitutively active G protein-coupled receptor mutants: Implications on receptor function and drug action [J].
Cotecchia, S ;
Fanelli, F ;
Costa, T .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (02) :311-316
[5]   Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers [J].
El-Asmar, L ;
Springael, JY ;
Ballet, S ;
Andrieu, EU ;
Vassart, G ;
Parmentier, M .
MOLECULAR PHARMACOLOGY, 2005, 67 (02) :460-469
[6]   Mechanism of constitutive activation of the AT1 receptor:: Influence of the size of the agonist switch binding residue Asn111 [J].
Feng, YH ;
Miura, SI ;
Husain, A ;
Karnik, SS .
BIOCHEMISTRY, 1998, 37 (45) :15791-15798
[7]   Agonist induction and conformational selection during activation of a G-protein-coupled receptor [J].
Hunyady, L ;
Vauquelin, G ;
Vanderheyden, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) :81-86
[8]   Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors [J].
Issafras, H ;
Angers, S ;
Bulenger, S ;
Blanpain, C ;
Parmentier, M ;
Labbé-Jullié, C ;
Bouvier, M ;
Marullo, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :34666-34673
[9]   Principles: Receptor theory in pharmacology [J].
Kenakin, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (04) :186-192
[10]   The ligand paradox between affinity and efficacy: can you be there and not make a difference? [J].
Kenakin, T ;
Onaran, O .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (06) :275-280